Search results for "Early disease"

showing 2 items of 2 documents

Proposal of a Citrus translational genomic approach for early and infield detection of Flavescence dorée in Vitis

2014

Flavescence dore´e (FD) is one of the most widely known grapevine yellows disease and one of the most unabated worldwide in the viticulture sector. In this paper, we outline a strategy for developing an integrated system of technologies to enable rapid, early disease FD detection and diagnosis. We propose the deployment of a newly developed sensor device, the differential mobility spectrometer (DMS), which has shown positive results with a similar vector-borne disease in Citrus. We have previously demonstrated that the gas chromatograph DMS (GC/DMS) can distinguish various citrus diseases, and the system may also allow detection of volatile organic compound (VOC) signals from a tree of othe…

0106 biological sciences0301 basic medicinePlant ScienceComputational biologyBiology01 natural sciences03 medical and health sciencesSettore AGR/07 - Genetica AgrariaBotanyProfile analysisPlant systemEcology Evolution Behavior and SystematicsDifferential mobility spectrometer early detection Flavescence dore´e phytoplasma qRT-PCR ELISA VitisfungiEarly diseasefood and beveragesSettore AGR/12 - Patologia VegetaleGrapevine yellowsSettore AGR/02 - Agronomia E Coltivazioni ErbaceeSettore AGR/03 - Arboricoltura Generale E Coltivazioni Arboree030104 developmental biologySettore AGR/14 - PedologiaFlavescence doréeGas chromatographyGas chromatography–mass spectrometryDisease transmission010606 plant biology & botany
researchProduct

New horizons in early stage COPD--improving knowledge, detection and treatment.

2011

SummaryEarly stage COPD carries a significant healthcare burden that is currently underrecognised, underdiagnosed and undertreated. Furthermore, patients at this stage can rapidly decline to advanced disease, especially if they continue to smoke. The natural history of the disease in early stages remains largely unknown, and emerging evidence indicates that we are able to reduce lung function decline and exacerbations, and improve quality of life, in early stage COPD, mainly through smoking cessation. But new evidence from randomised clinical trials also suggests an impact of pharmacotherapy on clinical outcomes in early disease. Guidelines need to be updated to reflect this greater underst…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyHealth Knowledge Attitudes Practicemedicine.medical_treatmentDiseasePulmonary Disease Chronic ObstructiveQuality of life (healthcare)PharmacotherapyHealth careDiagnosismedicineCOPDHumansIntensive care medicineCOPDbusiness.industryCase-findingEarly diseasemedicine.diseasePrognosisBronchodilator AgentsClinical trialNatural historyTreatmentEarly DiagnosisSpirometryPractice Guidelines as TopicPhysical therapyQuality of LifeSmoking cessationFemaleSmoking CessationbusinessRespiratory medicine
researchProduct